137 related articles for article (PubMed ID: 6419288)
1. The identification of hydroxy fatty acids in psoriatic skin.
Camp RD; Mallet AI; Woollard PM; Brain SD; Black AK; Greaves MW
Prostaglandins; 1983 Sep; 26(3):431-47. PubMed ID: 6419288
[TBL] [Abstract][Full Text] [Related]
2. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
Brain S; Camp R; Dowd P; Black AK; Greaves M
J Invest Dermatol; 1984 Jul; 83(1):70-3. PubMed ID: 6330213
[TBL] [Abstract][Full Text] [Related]
3. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
Fogh K; Herlin T; Kragballe K
J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
[TBL] [Abstract][Full Text] [Related]
4. Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin.
Grøn B; Iversen L; Ziboh V; Kragballe K
Arch Dermatol Res; 1993; 285(8):449-54. PubMed ID: 8274032
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of linoleic and arachidonic acids in VX2 carcinoma tissue: identification of monohydroxy octadecadienoic acids and monohydroxy eicosatetraenoic acids.
Hubbard WC; Hough AJ; Brash AR; Watson JT; Oates JA
Prostaglandins; 1980 Sep; 20(3):431-47. PubMed ID: 6775354
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids.
Camp RD; Fincham NJ
Br J Pharmacol; 1985 Aug; 85(4):837-41. PubMed ID: 2994785
[TBL] [Abstract][Full Text] [Related]
7. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
[TBL] [Abstract][Full Text] [Related]
8. Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids.
Camp RD; Cunningham FM; Fincham NJ; Greaves MW; Kobza Black A; Mallet AI; Woollard PM
Br J Pharmacol; 1988 Aug; 94(4):1043-50. PubMed ID: 3061542
[TBL] [Abstract][Full Text] [Related]
9. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
Kragballe K; Duell EA; Voorhees JJ
Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory properties of unsaturated fatty acids and their monohydroxy metabolites.
Cunningham FM; Woollard PM; Camp RD
Prostaglandins; 1985 Sep; 30(3):497-509. PubMed ID: 2997846
[TBL] [Abstract][Full Text] [Related]
12. 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro.
Cunningham FM; Woollard PM
Prostaglandins; 1987 Jul; 34(1):71-8. PubMed ID: 3317516
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization.
Fincham NJ; Camp RD; Gearing AJ; Bird CR; Cunningham FM
J Immunol; 1988 Jun; 140(12):4294-9. PubMed ID: 3286771
[TBL] [Abstract][Full Text] [Related]
14. Improved enantioselective analysis of polyunsaturated hydroxy fatty acids in psoriatic skin scales using high-performance liquid chromatography.
Bayer M; Mosandl A; Thaçi D
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):323-8. PubMed ID: 15833297
[TBL] [Abstract][Full Text] [Related]
15. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
[TBL] [Abstract][Full Text] [Related]
16. Lipid lymphocyte chemoattractants in psoriasis.
Bacon KB; Camp RD
Prostaglandins; 1990 Dec; 40(6):603-14. PubMed ID: 2093937
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.
Fogh K; Kiil J; Herlin T; Ternowitz T; Kragballe K
Arch Dermatol Res; 1987; 279(8):504-11. PubMed ID: 2829753
[TBL] [Abstract][Full Text] [Related]
18. Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.
Camp RD; Fincham NJ; Cunningham FM; Greaves MW; Morris J; Chu A
J Immunol; 1986 Dec; 137(11):3469-74. PubMed ID: 3491138
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4-like material in scale of psoriatic skin lesions.
Brain SD; Camp RD; Cunningham FM; Dowd PM; Greaves MW; Black AK
Br J Pharmacol; 1984 Sep; 83(1):313-7. PubMed ID: 6091827
[TBL] [Abstract][Full Text] [Related]
20. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
